Evidence map›Paper›PMID 40165562›Full record

ArticleThe American journal of psychiatry2025

Variability Rather Than Means? Harnessing the Adversary to Advance Precision Psychiatry.

Raquel E Gur, David R Roalf, Daniel H Wolf, Ruben C Gur

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raquel E GurNeurodevelopment and Psychosis Section, Department of Psychiatry, Perelman School of Medicine, and the Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia.
David R RoalfNeurodevelopment and Psychosis Section, Department of Psychiatry, Perelman School of Medicine, and the Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia.
Daniel H WolfNeurodevelopment and Psychosis Section, Department of Psychiatry, Perelman School of Medicine, and the Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia.
Ruben C GurNeurodevelopment and Psychosis Section, Department of Psychiatry, Perelman School of Medicine, and the Lifespan Brain Institute of the Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0002-9657-1996

Funding

Olfactory and facial markers of developmental risk for psychosis in 22q11 deletion syndromeR01MH119185 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2019 to 2024
$3.5M
NIMH NIH HHS R01 MH119185
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeuroanatomyNeuroimagingSchizophrenia Spectrum and Other Psychotic Disorders

Identifiers

PMID40165562
PMCPMC13088171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.